GlassScriptPhysician profile
Christopher Petrus
NPI 1982667622
$6,833.35
in general payments reported to CMS, 2019-2025
46 companies · $67.83 in 2025
The $67.83 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $669 · 2021: $919 · 2022: $1,527 · 2023: $1,027 · 2024: $1,874 · 2025: $67.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,139 · Travel and Lodging: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,139.30 |
| Travel and Lodging | $829.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,347.12 | 2022-2024 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $720.02 | 2019-2022 | |
| Janssen Biotech, INC. | $627.74 | 2019-2024 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $414.24 | 2023-2024 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $377.32 | 2019-2024 | Xiaflex, Aveed, Edex |
| Antares Pharma, INC. | $357.63 | 2020-2024 | Xyosted, Tlando, Nocdurna |
| Abbvie INC. | $347.07 | 2022-2024 | |
| Boston Scientific Corporation | $273.65 | 2019-2024 | |
| Allergan, INC. | $268.46 | 2019-2021 | |
| Urogen Pharma, INC. | $162.75 | 2020-2024 | Jelmyto |
| Coloplast Corp | $147.77 | 2019-2023 | Porges Coloplast, Speedicath |
| Urovant Sciences INC | $147.14 | 2021-2022 | |
| Myovant Sciences INC. | $126.48 | 2021-2022 | |
| Clarus Therapeutics INC. | $126.27 | 2021 | |
| Axonics, INC. | $121.07 | 2020-2023 | Axonics |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Petrus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.